Blog Topic: Immunotherapy

• 

  Chimeric Antigen Receptor Macrophage (CAR-M) Therapy for HER2 Overexpressing Solid Tumors

  April 29, 2022

  Penn Medicine is one of five sites participating in a first-in-human Phase 1 study evaluating the potential of CAR M cell therapy in recurrent or metastatic HER2-overexpressing solid tumors.

  Immunotherapy Oncology
• 

  CAR T Cell Therapy for Medullary Thyroid Cancer Trial Now Enrolling at the Abramson Cancer Center

  February 17, 2022

  Drs. Roger Cohen and Donald Siegel are conducting an enrolling clinical trial at Penn for a novel CAR T therapy for medullary thyroid cancer.

  Oncology Immunotherapy
• 

  Collateral Damage: CAR T, COVID and the Cytokine Storm - Advances at Penn Medicine and the Abramson Cancer Center

  August 19, 2021

  In its association with CAR T therapy, cytokine storm was discovered at Penn Medicine, and has been a source of study ever since.

  COVID-19 Immunotherapy Oncology
• 

  Monoclonal Antibody Combo for COVID-19: REGEN-COV Shot Reduces Progression to Symptomatic Disease, Viral Burden

  May 04, 2021

  Data from a clinical trial co-led by Penn Medicine’s Katharine J. Bar, MD, suggests that Regeneron’s monoclonal antibody shot, “REGEN-COV”, can reduce the risk of asymptomatic to symptomatic COVID-19 infection progression by almost one third.

  COVID-19 Immunotherapy
• 

  The Next Pandemic: Takeaways from a Discussion with Drs. Susan R. Weiss and Frederic Bushman for The Perry World House at Penn

  April 07, 2021

  In a recent seminar, Perelman School of Medicine microbiologist Frederic Bushman, PhD, and virologist Susan R. Weiss, PhD, considered the next pandemic and its origins.

  Immunotherapy COVID-19
• 

  Penn Research: COVID-19 Survivors at Risk for Autoimmunity

  February 09, 2021

  According to new research at Penn Medicine, COVID-19 survivors are at risk for progression to a state resembling autoimmune disease.

  COVID-19 Immunotherapy
• 

  How SARS-CoV-1, MERS, and Penn Medicine Research contributed to the fastest vaccine turn-around in history

  February 09, 2021

  Research at the Perelman School of Medicine in mRNA and the coronaviruses predated SARS, MERS, and COVID-19--and contributed to the fastest advent for a vaccine in history.

  COVID-19 Immunotherapy
• 

  Dexamethasone and COVID-19: The Randomized Evaluation of COVID-19 Therapy (RECOVERY) Trial

  November 13, 2020

  The Randomized Evaluation of COVID-19 Therapy (RECOVERY) study evaluated immunosuppressant therapy in SARS-Co-V2.

  COVID-19 Immunotherapy Pulmonology
• 

  Shingles Vaccine and IBD Research at Penn

  April 01, 2020

  Researchers at Penn GI have been investigating the safety of herpes zoster vaccination (HZV) among IBD patients on anti-TNF therapy.

  Gastroenterology, Hepatology and GI Surgery Immunotherapy
• 

  Advances in Kidney Transplantation: Eradicating Hepatitis C in Patients Following Lifesaving Transplants from Infected Donors

  August 31, 2019

  Drs. Peter Reese and David Goldberg at Penn Gastroenterology have successfully cured hepatitis C (HCV) infection in kidney-transplant patients who received organs from HCV+ donors.

  Transplant Surgery Immunotherapy